Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Jessica Donington

Concepts (361)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
43
2020
901
11.630
Why?
Lung Neoplasms
62
2020
2046
11.090
Why?
Pneumonectomy
18
2020
178
6.060
Why?
Neoplasm Staging
33
2020
1900
3.090
Why?
Thoracic Surgery
6
2020
30
2.830
Why?
Osteopontin
6
2013
51
2.400
Why?
Radiosurgery
8
2018
207
2.030
Why?
Physicians, Women
4
2020
46
1.700
Why?
Adenocarcinoma
11
2016
1225
1.440
Why?
Pleural Neoplasms
11
2016
180
1.410
Why?
Humans
107
2021
77711
1.380
Why?
Mesothelioma
13
2016
292
1.330
Why?
Esophagectomy
5
2009
83
1.320
Why?
Early Detection of Cancer
2
2020
281
1.270
Why?
Small Cell Lung Carcinoma
3
2020
79
1.150
Why?
Disease Management
3
2019
310
1.070
Why?
Tomography, X-Ray Computed
11
2020
2511
1.010
Why?
Catheter Ablation
6
2015
281
0.980
Why?
Neoplasm Recurrence, Local
10
2017
1140
0.940
Why?
Specialties, Surgical
1
2020
52
0.880
Why?
Antibody Formation
1
2020
200
0.870
Why?
Societies, Medical
3
2020
500
0.840
Why?
Antibodies, Viral
2
2021
305
0.840
Why?
Surgical Flaps
3
2017
260
0.820
Why?
Esophageal Neoplasms
4
2009
359
0.810
Why?
Carcinoma, Squamous Cell
5
2016
1015
0.790
Why?
Neoplasms, Second Primary
5
2016
225
0.780
Why?
Thoracic Surgical Procedures
2
2019
39
0.770
Why?
Mass Screening
2
2020
607
0.750
Why?
Probability
1
2017
350
0.700
Why?
Skin Ulcer
1
2016
23
0.700
Why?
Salvage Therapy
2
2017
215
0.690
Why?
Frozen Sections
1
2015
46
0.650
Why?
Skin Transplantation
1
2016
166
0.640
Why?
Combined Modality Therapy
10
2019
1640
0.630
Why?
Esophagus
2
2006
116
0.610
Why?
Monitoring, Intraoperative
1
2015
140
0.600
Why?
Female
40
2021
42391
0.600
Why?
Prognosis
15
2019
3519
0.580
Why?
Fluorodeoxyglucose F18
3
2012
120
0.580
Why?
Pancoast Syndrome
1
2013
2
0.580
Why?
Radiopharmaceuticals
3
2012
163
0.570
Why?
Treatment Outcome
12
2020
7472
0.560
Why?
Male
36
2021
39938
0.550
Why?
Fas Ligand Protein
1
2013
48
0.540
Why?
Positron-Emission Tomography
5
2013
265
0.530
Why?
Middle Aged
29
2021
24492
0.530
Why?
Aged
24
2020
17612
0.520
Why?
Fluorine Radioisotopes
1
2012
14
0.510
Why?
Cyclooxygenase 2
1
2012
94
0.490
Why?
Skin Neoplasms
1
2016
510
0.490
Why?
Radiation Injuries
2
2010
161
0.490
Why?
Neurosurgical Procedures
1
2013
174
0.480
Why?
Bronchogenic Cyst
1
2010
5
0.470
Why?
Radium
2
2020
5
0.470
Why?
Thoracic Wall
1
2010
20
0.460
Why?
Soft Tissue Infections
1
2010
21
0.460
Why?
Thoracic Diseases
1
2010
29
0.460
Why?
Clinical Trials as Topic
4
2020
1157
0.440
Why?
United States
10
2020
5848
0.440
Why?
Survival Analysis
4
2019
1565
0.410
Why?
Thoracic Surgery, Video-Assisted
3
2016
22
0.410
Why?
Adult
23
2021
24687
0.400
Why?
Health Status Disparities
1
2011
134
0.400
Why?
Neoplasm Proteins
1
2012
530
0.380
Why?
Neoadjuvant Therapy
3
2020
258
0.370
Why?
Chemotherapy, Adjuvant
3
2019
478
0.370
Why?
Dumping Syndrome
1
2006
5
0.340
Why?
Healthcare Disparities
1
2011
300
0.340
Why?
Gastric Emptying
1
2006
19
0.340
Why?
Retrospective Studies
9
2020
6816
0.330
Why?
Aged, 80 and over
14
2016
6299
0.320
Why?
Deglutition Disorders
1
2006
81
0.320
Why?
Wounds, Nonpenetrating
1
2006
62
0.320
Why?
Antineoplastic Agents
5
2020
2307
0.320
Why?
Stomach
1
2006
117
0.310
Why?
Esophageal Diseases
1
2005
30
0.310
Why?
Gastroesophageal Reflux
1
2006
110
0.310
Why?
Transcription Factors
1
2013
1455
0.310
Why?
Patient Care Management
2
2020
29
0.310
Why?
Intubation, Intratracheal
1
2006
129
0.300
Why?
Survival Rate
8
2016
1896
0.300
Why?
Patient Selection
3
2020
674
0.300
Why?
Coronavirus Infections
2
2020
287
0.300
Why?
Pneumonia, Viral
2
2020
313
0.290
Why?
General Surgery
1
2007
208
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2011
2187
0.280
Why?
Hamartoma
1
2003
34
0.280
Why?
Risk Assessment
6
2020
2155
0.270
Why?
Medical Oncology
1
2007
299
0.270
Why?
Antibodies, Neutralizing
2
2021
117
0.270
Why?
Negative-Pressure Wound Therapy
2
2014
9
0.270
Why?
Carcinoma, Bronchogenic
1
2002
32
0.260
Why?
Lymphatic Metastasis
4
2010
499
0.260
Why?
Education, Medical, Graduate
2
2019
306
0.240
Why?
Neoplasm Metastasis
3
2019
1015
0.240
Why?
Funnel Chest
1
2021
7
0.240
Why?
Pneumothorax
2
2020
49
0.240
Why?
Chemoradiotherapy
2
2020
242
0.240
Why?
Lung Diseases
1
2003
279
0.230
Why?
Immunization, Passive
1
2020
77
0.230
Why?
SEER Program
2
2011
191
0.220
Why?
Critical Pathways
1
2020
34
0.220
Why?
Sexual Harassment
1
2019
5
0.220
Why?
Riots
1
2019
1
0.210
Why?
Case-Control Studies
4
2013
1747
0.210
Why?
Nontuberculous Mycobacteria
1
2018
8
0.210
Why?
Protein Isoforms
2
2010
260
0.210
Why?
Mycobacterium Infections, Nontuberculous
1
2018
18
0.200
Why?
Drainage
1
2020
169
0.200
Why?
Pandemics
2
2020
390
0.200
Why?
Randomized Controlled Trials as Topic
2
2020
817
0.200
Why?
Thoracotomy
1
2018
51
0.190
Why?
Immunoglobulin G
1
2020
458
0.190
Why?
Cost-Benefit Analysis
1
2020
381
0.190
Why?
Radiotherapy, Adjuvant
2
2013
303
0.190
Why?
Respiratory System
1
2018
105
0.190
Why?
Periodicals as Topic
1
2020
165
0.190
Why?
Cohort Studies
5
2012
2526
0.190
Why?
Diagnosis, Differential
4
2013
1578
0.190
Why?
Wound Closure Techniques
1
2017
12
0.190
Why?
Consolidation Chemotherapy
1
2017
21
0.180
Why?
Thoracic Neoplasms
1
2017
61
0.180
Why?
Prosthesis-Related Infections
1
2017
46
0.180
Why?
Evidence-Based Medicine
2
2017
430
0.170
Why?
Risk Factors
4
2013
5095
0.170
Why?
Lymph Nodes
2
2011
517
0.170
Why?
Meta-Analysis as Topic
4
2016
103
0.160
Why?
Asbestos
2
2012
22
0.160
Why?
National Cancer Institute (U.S.)
1
2015
62
0.160
Why?
Defibrillators, Implantable
1
2017
121
0.160
Why?
Cell Proliferation
2
2013
1551
0.160
Why?
Surgical Wound Infection
1
2017
178
0.160
Why?
Forecasting
1
2016
305
0.160
Why?
Subcutaneous Emphysema
1
2014
6
0.160
Why?
Biopsy
2
2016
1128
0.160
Why?
Photochemotherapy
1
1995
97
0.150
Why?
Simian virus 40
4
1998
34
0.150
Why?
Immunotherapy
1
2020
489
0.150
Why?
Apoptosis
2
2013
1745
0.150
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2013
914
0.150
Why?
Area Under Curve
2
2012
340
0.150
Why?
Receptor, EphB2
1
2013
2
0.140
Why?
Radiography
2
2014
863
0.140
Why?
Neoplasm, Residual
2
2019
123
0.140
Why?
Neoplasm Invasiveness
2
2013
522
0.140
Why?
Peritoneum
1
2013
47
0.140
Why?
Protein Kinase Inhibitors
1
2018
539
0.140
Why?
Clinical Protocols
1
2013
154
0.130
Why?
Epithelium
1
2013
311
0.130
Why?
ROC Curve
2
2012
773
0.130
Why?
Blotting, Western
2
2013
830
0.130
Why?
Pain Management
1
2013
107
0.130
Why?
Clinical Trials, Phase III as Topic
2
2007
145
0.130
Why?
Occupational Exposure
1
2012
67
0.130
Why?
Extracellular Matrix Proteins
1
2012
132
0.120
Why?
Job Satisfaction
1
2012
63
0.120
Why?
Postoperative Complications
2
2020
2190
0.120
Why?
Solitary Pulmonary Nodule
1
2013
173
0.120
Why?
Radiotherapy, Computer-Assisted
1
2011
24
0.120
Why?
Young Adult
5
2021
5498
0.120
Why?
Palliative Care
1
2013
243
0.120
Why?
Sternoclavicular Joint
1
2010
2
0.120
Why?
Carcinoma, Large Cell
1
2011
41
0.120
Why?
Pulmonary Surgical Procedures
1
2010
3
0.120
Why?
Colony-Forming Units Assay
1
2010
43
0.120
Why?
Internship and Residency
1
2019
837
0.120
Why?
Opioid-Related Disorders
1
2012
101
0.120
Why?
Cranial Irradiation
2
2020
36
0.120
Why?
Ribonucleases
1
2011
87
0.110
Why?
Debridement
1
2010
66
0.110
Why?
Models, Anatomic
1
2011
89
0.110
Why?
Computer-Assisted Instruction
1
2011
44
0.110
Why?
Cell Movement
2
2013
733
0.110
Why?
Epithelial-Mesenchymal Transition
1
2010
64
0.110
Why?
Functional Laterality
1
2011
203
0.110
Why?
Models, Cardiovascular
1
2011
98
0.110
Why?
Necrosis
1
2010
202
0.110
Why?
Tumor Burden
2
2011
271
0.110
Why?
Tuberculosis
1
2010
61
0.110
Why?
Joint Diseases
1
2010
49
0.110
Why?
Tumor Cells, Cultured
3
2009
1089
0.110
Why?
Oligonucleotide Array Sequence Analysis
2
2010
699
0.110
Why?
Tracheal Neoplasms
1
2009
7
0.110
Why?
Prospective Studies
5
2018
3719
0.110
Why?
Glomus Tumor
1
2009
5
0.110
Why?
Cell Line, Tumor
3
2011
2326
0.110
Why?
Pain, Postoperative
1
2012
209
0.110
Why?
Antibodies, Monoclonal
1
2017
1479
0.110
Why?
Chest Pain
1
2009
40
0.110
Why?
Cell Adhesion
1
2010
424
0.100
Why?
Sarcoidosis
1
2010
89
0.100
Why?
MicroRNAs
2
2011
464
0.100
Why?
Enzyme-Linked Immunosorbent Assay
1
2010
400
0.100
Why?
Endosonography
1
2010
126
0.100
Why?
Mediastinal Neoplasms
2
2005
51
0.100
Why?
Length of Stay
2
2020
641
0.100
Why?
Analgesics, Opioid
1
2012
314
0.100
Why?
Microwaves
1
2008
28
0.100
Why?
RNA, Messenger
2
2013
1971
0.090
Why?
Wound Healing
1
2010
334
0.090
Why?
NF-kappa B
1
2011
414
0.090
Why?
Chest Tubes
2
2020
20
0.090
Why?
Vascular Endothelial Growth Factor A
1
2009
369
0.090
Why?
Time Factors
3
2012
5346
0.090
Why?
DNA, Viral
2
1998
267
0.090
Why?
Receptor, IGF Type 1
2
1998
42
0.090
Why?
Sex Factors
1
2011
1059
0.090
Why?
African Continental Ancestry Group
1
2010
555
0.090
Why?
Pulmonary Ventilation
1
2006
36
0.090
Why?
Neovascularization, Pathologic
1
2009
364
0.090
Why?
Gene Expression Profiling
2
2010
1311
0.090
Why?
Diagnostic Imaging
1
2011
436
0.090
Why?
Cognition
1
2011
468
0.090
Why?
Sialoglycoproteins
1
2006
35
0.080
Why?
Carbonic Anhydrases
1
2006
13
0.080
Why?
Mediastinoscopy
1
2005
6
0.080
Why?
Sex Distribution
1
2006
172
0.080
Why?
Computer Simulation
1
2011
1016
0.080
Why?
Thoracic Injuries
1
2006
29
0.080
Why?
Disease-Free Survival
2
2011
1200
0.080
Why?
California
1
2006
131
0.080
Why?
Hemangioendothelioma, Epithelioid
1
2005
9
0.080
Why?
History, 21st Century
2
2017
174
0.080
Why?
Esophagoplasty
1
2005
9
0.080
Why?
Anesthetics
1
2005
57
0.080
Why?
Radiotherapy Dosage
1
2006
456
0.080
Why?
Blood Loss, Surgical
1
2005
104
0.080
Why?
European Continental Ancestry Group
1
2010
1063
0.080
Why?
Risk
1
2006
689
0.070
Why?
Peritoneal Neoplasms
2
1998
193
0.070
Why?
Antigens, Neoplasm
1
2006
295
0.070
Why?
Follow-Up Studies
3
2016
3681
0.070
Why?
Adolescent
3
2021
8667
0.070
Why?
Preoperative Care
1
2005
405
0.060
Why?
Asthma
1
2009
794
0.060
Why?
Smoking
1
2006
557
0.060
Why?
Hospital Mortality
1
2003
298
0.060
Why?
Cross Reactions
1
2021
133
0.060
Why?
Transfection
3
2011
937
0.060
Why?
Oxygen
1
2006
678
0.060
Why?
Antigens, Viral
1
2021
157
0.060
Why?
Immunity, Humoral
1
2021
66
0.060
Why?
Bioethics
1
2020
34
0.060
Why?
Risk Management
1
2020
45
0.060
Why?
Etoposide
1
2020
196
0.050
Why?
Epitopes
1
2021
297
0.050
Why?
Asbestosis
2
1998
5
0.050
Why?
Practice Guidelines as Topic
2
2018
1060
0.050
Why?
Phosphoproteins
1
2021
263
0.050
Why?
Sputum
1
2018
25
0.050
Why?
Interdisciplinary Communication
1
2020
133
0.050
Why?
Tumor Virus Infections
1
1998
82
0.050
Why?
Bronchoalveolar Lavage Fluid
1
2018
125
0.050
Why?
Infection Control
1
2020
130
0.050
Why?
Self Report
1
2019
238
0.050
Why?
Oligonucleotides, Antisense
1
1998
70
0.050
Why?
Electrocardiography
1
2021
533
0.050
Why?
Regulatory Sequences, Nucleic Acid
1
1998
142
0.050
Why?
RNA, Ribosomal, 16S
1
2018
230
0.050
Why?
Heart
1
2021
504
0.050
Why?
Pilot Projects
2
2012
774
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
140
0.040
Why?
RNA, Antisense
1
1996
16
0.040
Why?
Papillomavirus Infections
1
1998
145
0.040
Why?
Feasibility Studies
2
1996
703
0.040
Why?
Chemotherapy, Cancer, Regional Perfusion
1
1996
17
0.040
Why?
Receptor, erbB-2
1
2018
188
0.040
Why?
Comorbidity
1
2020
870
0.040
Why?
Anniversaries and Special Events
1
2016
10
0.040
Why?
Protein-Tyrosine Kinases
1
2018
295
0.040
Why?
Sensitivity and Specificity
2
2012
2074
0.040
Why?
Proto-Oncogene Proteins c-met
1
2018
209
0.040
Why?
Consensus
1
2017
254
0.040
Why?
Radiation Oncology
1
2017
100
0.040
Why?
B-Lymphocytes
1
2021
760
0.040
Why?
Chromosome Disorders
1
1995
122
0.040
Why?
National Institutes of Health (U.S.)
1
1995
99
0.040
Why?
Heart Ventricles
1
2021
713
0.040
Why?
Genes, Tumor Suppressor
1
1995
166
0.040
Why?
Clinical Trials, Phase II as Topic
1
1995
169
0.040
Why?
Clinical Trials, Phase I as Topic
1
1995
152
0.040
Why?
History, 20th Century
1
2016
314
0.040
Why?
Base Sequence
2
1996
2399
0.040
Why?
Proto-Oncogene Proteins
1
2018
657
0.040
Why?
Genetic Testing
1
2018
475
0.030
Why?
Chromosome Aberrations
1
1995
397
0.030
Why?
DNA Damage
1
1995
344
0.030
Why?
Molecular Sequence Data
2
1996
3166
0.030
Why?
Immunohistochemistry
1
2018
1783
0.030
Why?
Immunoenzyme Techniques
1
2013
329
0.030
Why?
Pleural Effusion, Malignant
1
2012
12
0.030
Why?
Pleural Effusion
1
2012
48
0.030
Why?
Fluorescent Antibody Technique
1
2013
336
0.030
Why?
Cricetinae
3
1998
576
0.030
Why?
Reactive Oxygen Species
1
1995
448
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
280
0.030
Why?
Fear
1
2012
63
0.030
Why?
Tumor Necrosis Factor-alpha
1
1996
677
0.030
Why?
Self Concept
1
2012
132
0.030
Why?
Recurrence
1
2014
1125
0.030
Why?
Cytokines
1
1995
712
0.030
Why?
Thoracoscopes
1
2011
2
0.030
Why?
Surgical Staplers
1
2011
11
0.030
Why?
RNA, Small Interfering
1
2013
566
0.030
Why?
Dissection
1
2011
45
0.030
Why?
Taxoids
1
2011
131
0.030
Why?
Computer Graphics
1
2011
99
0.030
Why?
Carboplatin
1
2011
244
0.030
Why?
Community-Based Participatory Research
1
2010
37
0.030
Why?
Motor Skills
1
2011
75
0.030
Why?
Radiography, Thoracic
1
2013
403
0.030
Why?
Patient Positioning
1
2011
64
0.030
Why?
Child
1
2021
6303
0.030
Why?
Mediastinum
1
2010
46
0.030
Why?
Kaplan-Meier Estimate
1
2012
896
0.030
Why?
Affect
1
2012
377
0.030
Why?
Biopsy, Needle
1
2010
268
0.030
Why?
Multivariate Analysis
1
2012
1008
0.030
Why?
Down-Regulation
1
2011
514
0.030
Why?
Longitudinal Studies
1
2012
899
0.030
Why?
Depression
1
2012
375
0.020
Why?
Empyema
1
2008
11
0.020
Why?
Cells, Cultured
1
2013
2901
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2006
1171
0.020
Why?
Insulin-Like Growth Factor I
2
1998
116
0.020
Why?
Plasmids
2
1998
291
0.020
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.020
Why?
Tracheal Diseases
1
2005
11
0.020
Why?
Lymphatic Diseases
1
2005
38
0.020
Why?
Regression Analysis
1
2007
618
0.020
Why?
Incidence
1
2010
1540
0.020
Why?
Age Factors
1
2010
1860
0.020
Why?
Clinical Competence
1
2011
664
0.020
Why?
Polymerase Chain Reaction
2
1998
988
0.020
Why?
Predictive Value of Tests
1
2010
1626
0.020
Why?
Animals
4
1998
25944
0.020
Why?
Lymphoma, Non-Hodgkin
1
2005
258
0.020
Why?
Reproducibility of Results
1
2010
2574
0.020
Why?
Disease Progression
1
2007
1385
0.020
Why?
Lung
1
2006
1025
0.010
Why?
Gene Expression Regulation, Viral
1
1998
89
0.010
Why?
HSP70 Heat-Shock Proteins
1
1998
108
0.010
Why?
Virus Replication
1
1998
319
0.010
Why?
Oxygenators
1
1996
3
0.010
Why?
Carcinoma, Adenoid Cystic
1
1996
22
0.010
Why?
Sarcoma, Ewing
1
1996
40
0.010
Why?
Cardiac Output
1
1996
150
0.010
Why?
Safety
1
1996
164
0.010
Why?
Hyperthermia, Induced
1
1996
73
0.010
Why?
Cell Transformation, Neoplastic
1
1998
407
0.010
Why?
Cell Division
1
1996
757
0.010
Why?
Pulmonary Artery
1
1996
286
0.010
Why?
Remission Induction
1
1996
689
0.010
Why?
Interferon-gamma
1
1996
436
0.010
Why?
Sarcoma
1
1996
224
0.010
Why?
Carcinoma, Renal Cell
1
1996
355
0.010
Why?
Melanoma
1
1996
470
0.010
Why?
Transcription, Genetic
1
1996
1146
0.010
Why?
Blood Pressure
1
1996
1147
0.010
Why?
Rats
1
1996
4296
0.010
Why?
Donington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_